Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia.

Kayikcioglu, Meral; Tokgozoglu, Lale; Tuncel, Ozlem Kuman; Pirildar, Sebnem; Can, Levent

Kayikcioglu, Meral; Tokgozoglu, Lale; Tuncel, Ozlem Kuman; Pirildar, Sebnem; Can, Levent.

Kayikcioglu M; Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey. Electronic address: meral.kayikcioglu@gmail.com.
Tokgozoglu L; Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey.
Tuncel OK; Ege University Medical Faculty, Department of Psychiatry, Izmir, Turkey.
Pirildar S; Ege University Medical Faculty, Department of Psychiatry, Izmir, Turkey.
Can L; Ege University Medical Faculty, Department of Cardiology, Izmir, Turkey.

J Clin Lipidol ; 14(6): 751-755, 2020.

Article in English | MEDLINE | ID: covidwho-758962

Subject(s)

COVID-19; Homozygote; Hyperlipoproteinemia Type II/therapy; Life Style; Pandemics; SARS-CoV-2; COVID-19/epidemiology; COVID-19/genetics; COVID-19/therapy; Female; Humans; Hyperlipoproteinemia Type II/genetics; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / SARS-CoV-2 / COVID-19 / Homozygote / Hyperlipoproteinemia Type II / Life Style Type of study: Experimental Studies / Observational study Limits: Female / Humans / Male Language: English Journal: J Clin Lipidol Journal subject: Biochemistry / Metabolism Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google